Back to Journals » OncoTargets and Therapy » Volume 11

Original Research

Afatinib versus gemcitabine/cisplatin for first-line treatment of Chinese patients with advanced non-small-cell lung cancer harboring EGFR mutations: subgroup analysis of the LUX-Lung 6 trial

       
Total article views   HTML views PDF downloads Totals
10,584 Dovepress* 9,439+ 1,290 10,729
PubMed Central* 1,145 442 1,587
Totals 10,584 1,732 12,316
*Since 30 November 2018
Total mentioned Facebook Delicious Reddit Twitter Others
6 0 0 1 1 4

View citations on PubMed Central and Google Scholar